D-dimer in blood test

The role of D-dimer in the assessment of the hemostatic system

In modern clinical practice, the concentration of D-dimer is evaluated as part of a comprehensive basic test — the coagulogram. The main purpose of this analysis is an objective assessment of the patient's bleeding risk. A direct clinical indication for prescribing an expanded coagulogram is a decreased platelet count detected in a complete blood count (CBC).

In addition to D-dimer, the standard mandatory hemostasis assessment profile invariably includes the following parameters:

• Prothrombin time (PT) in blood plasma.
• INR (International Normalized Ratio).
• aPTT (Activated Partial Thromboplastin Time).
• Fibrinogen.
• Thrombin time.

A more detailed laboratory screening may additionally include antithrombin III activity and plasminogen levels. Joint analysis of these indicators allows the attending physician to obtain a reliable picture of the functioning of the procoagulant and anticoagulant systems.

D-dimer and diagnosis of DIC syndrome

One of the primary objectives of measuring D-dimer concentration is the timely diagnosis of disseminated intravascular coagulation (DIC syndrome). This severe life-threatening coagulopathy can develop as an atypical complication in various pathologies. In particular, the development of DIC syndrome is rarely recorded in the setting of infectious diseases, such as West Nile fever.

The classic laboratory picture of DIC syndrome development in coagulogram results includes the following triad of signs:

1. Pathological increase in D-dimer concentration.
2. A sharp drop in plasma fibrinogen levels.
3. Clinically significant prolongation of prothrombin time (PT) and aPTT.

To determine the severity of developed DIC syndrome, medical practice worldwide uses a specialized scoring system by the International Society on Thrombosis and Haemostasis — the ISTH 2001 scale. When overt DIC syndrome accompanied by pronounced bleeding is detected, additional diagnostic algorithms are used to quickly make decisions on initiating replacement therapy.

Acute conditions: ectopic pregnancy and bleeding

Emergency clinical situations dictate the need for special attention to hemostatic parameters. Patients with confirmed ectopic pregnancy and signs of bleeding have an extremely high risk of developing severe coagulopathy. In these situations, strict monitoring is required to rule out or confirm DIC syndrome.

The mandatory diagnostic scope of laboratory tests in such cases includes:

• Basic coagulogram (assessment of fibrinogen, INR, and aPTT).
• Expanded complete blood count.
• Determination of blood D-dimer concentration.

Under conditions of ongoing active bleeding, it is most appropriate to use methods of thromboelastography or thromboelastometry (TEG/ROTEM). These instrumental methods allow for continuous monitoring of the coagulation system directly during bleeding, which is critical for the immediate correction of patient management tactics.

The role of coagulogram in clinical guidelines

The study of coagulation parameters, including D-dimer, is strictly regulated by clinical guidelines when examining patients with suspected upper urinary tract tumors. Indications for a comprehensive examination, which also includes a CBC and general therapeutic blood chemistry, include manifestations such as macrohematuria, intense pain in the lumbar region, and the presence of a palpable mass.

The coagulogram in patients of this group aims to assess risks and select the safest treatment tactics. Upon confirmation of the diagnosis of an upper urinary tract tumor, the range of mandatory tests is additionally expanded by conducting a bacteriological urine culture (urine culture) to identify concurrent infectious factors that could affect therapy.

When hemostasis testing can be omitted

Despite the high clinical significance of D-dimer evaluation, there are situations when omitting a coagulogram is acceptable. A strict condition for this is the complete absence of clinical signs indicating hemostatic pathology in the patient.

The test may be omitted in the following situations:

• During a patient follow-up visit.
• Immediately before starting a new treatment cycle.
• At the stage of assessing achieved disease remission.
• During routine control examinations.
• In case of suspected relapse (without hemorrhagic manifestations).

Such an approach helps avoid overdiagnosis and optimize the laboratory workload.

Class and exam questions

What else to study on this topic

• Application of thromboelastography (TEG/ROTEM) for monitoring massive bleeding.
• Principles of the ISTH 2001 scale for assessing coagulopathy severity.
• Differential diagnosis of the causes of decreased plasma fibrinogen levels.
• Clinical significance of INR and prothrombin time when planning therapy.
• Algorithms for emergency diagnosis of DIC syndrome in intra-abdominal bleeding.

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.